0001468492 false 0001468492 2023-11-22 2023-11-22 0001468492 HSCS:CommonStock0.001ParValuePerShareMember 2023-11-22 2023-11-22 0001468492 HSCS:WarrantsToPurchaseCommonStockMember 2023-11-22 2023-11-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 22, 2023

 

HEART TEST LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

Texas   001-41422   26-1344466
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

550 Reserve Street, Suite 360

Southlake, Texas 76092

(Address of principal executive offices)(Zip Code)

 

Registrant’s telephone number, including area code: 682-237-7781

 

n/a

(Former Name or Former Address, if Changed Since Last Report) 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

  

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.001 par value per share   HSCS   The Nasdaq Stock Market LLC
Warrants to purchase common stock   HSCSW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 8.01. Other Events.

 

On November 22, 2023, Heart Test Laboratories, Inc. (the “Company”) was formally notified by the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has evidenced compliance with all applicable requirements for continued listing on The Nasdaq Capital Market, including the $2.5 million stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1). Pursuant to Nasdaq Listing Rule 5815(d)(4)(B), the Company remains subject to a Panel Monitor through November 22, 2024.

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HEART TEST LABORATORIES, INC.
   
  By: /s/ Andrew Simpson 
Date: November 27, 2023 Name: Andrew Simpson
  Title: President, Chief Executive Officer and
Chairman of the Board of Directors

 

 

2

 

 

v3.23.3
Cover
Nov. 22, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 22, 2023
Entity File Number 001-41422
Entity Registrant Name HEART TEST LABORATORIES, INC.
Entity Central Index Key 0001468492
Entity Tax Identification Number 26-1344466
Entity Incorporation, State or Country Code TX
Entity Address, Address Line One 550 Reserve Street, Suite 360
Entity Address, City or Town Southlake
Entity Address, State or Province TX
Entity Address, Postal Zip Code 76092
City Area Code 682
Local Phone Number 237-7781
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common stock, $0.001 par value per share  
Title of 12(b) Security Common stock, $0.001 par value per share
Trading Symbol HSCS
Security Exchange Name NASDAQ
Warrants to purchase common stock  
Title of 12(b) Security Warrants to purchase common stock
Trading Symbol HSCSW
Security Exchange Name NASDAQ
HeartSciences (NASDAQ:HSCS)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more HeartSciences Charts.
HeartSciences (NASDAQ:HSCS)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more HeartSciences Charts.